Opioids Tough To Prescribe For Legitimate Patients, Doctors Say
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
THURSDAY, April 24, 2025 — Patients who legitimately need opioid painkillers are finding it more difficult to get the meds they need, due to guardrails established in response to the U.S. opioid crisis, a new study says.
Doctors who treat patients in severe pain said they frequently encounter obstacles when prescribing opioid painkillers, researchers reported in the journal NEJM Catalyst Innovations In Care Delivery.
“The opioid crisis of overdose deaths remains omnipresent; however, a new threat has emerged among vulnerable populations who need these medicines as first-line treatment for their pain, which can be severe,” lead researcher Dr. Rebecca Rodin said in a news release. Rodin is an assistant professor of geriatrics and palliative medicine at the Icahn Mount School of Medicine at Mount Sinai in New York City.
Opioids are sometimes needed to counter severe pain in patients with cancer or conditions like sickle cell, researchers said in background notes.
However, more than 720,000 people have died in the U.S. since 1999 from opioid overdoses, in an ongoing crisis that led policymakers to tighten opioid prescribing methods.
To see how these restrictions have affected treatment, researchers surveyed 52 palliative care doctors and nurses within the Mount Sinai Health System.
Results showed that:
A major problem is scattered and uneven availability of opioids among pharmacies, researchers reported.
“Our clinicians told us that in New York City’s outer boroughs, such as the Bronx, Brooklyn, and Queens, they encountered much greater difficulty obtaining opioids where we treat higher concentrations of underrepresented patients who are socioeconomically vulnerable,” Rodin said.
Mount Sinai doctors have tried a three-pronged approach to make opioid meds more available to those in need, researchers say.
First, they reached out to key pharmacies to explain why these painkillers are needed, and the importance of keeping them in stock.
The team also developed education programs for providers to explain when and why opioid painkillers are necessary, the study says.
And finally, the team crafted a guide to preferred pharmacies so that doctors will know where to turn when opioids are needed during a pain crisis.
“Our strategies have been effective within the Mount Sinai ecosystem, but they do not address root causes of barriers which can include a number of factors, such as much broader supply chain shortages at the regional and national level, public and private coverage policies, and pharmacy stocking and dispensing practices,” Rodin said. “We need to do more to address these barriers.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-25 00:00
Read more

- FDA Approves Imfinzi (durvalumab) for Muscle Invasive Bladder Cancer
- Eviction Bans Linked To Drop In Child Abuse Reports
- Common Meds Appear To Delay Onset Of Parkinson's Disease
- WHO Announces Completion of Draft Pandemic Agreement
- RFK Jr. Touts Vaccine While at Funeral of Texas Girl Who Died of Measles
- ACC: Bilateral Oophorectomy Linked to Increased Risk for Heart Failure
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions